The pharmacologic treatment of erectile failure is now a reality. However, current agents have major drawbacks. Some require invasive administration, whereas others offer only marginal effect. The use of hormones should be limited to well-documented cases of endocrine dysfunction. Oral and transcutaneous agents remain experimental, but new drugs are under investigation and show early encouraging results.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
oral transcutaneous
8
transcutaneous pharmacologic
4
pharmacologic agents
4
agents treatment
4
treatment impotence
4
impotence pharmacologic
4
pharmacologic treatment
4
treatment erectile
4
erectile failure
4
failure reality
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!